VA-DXC-TECHNOLOGY
15.1.2019 15:02:11 CET | Business Wire | Press release
A vast majority of businesses will increase their investments in digital technology over the coming year, and many expect IT modernization to fuel future transformation efforts that lead to cost savings and greater profitability. These are some of the findings from a new global survey conducted by The Economist Intelligence Unit (EIU) and commissioned by DXC Technology (NYSE: DXC), the world’s leading independent, end-to-end IT services company.
The study, “2019: The Year of Digital Decisions ,” explores how companies define digital transformation and the resulting business outcomes. Significantly, the report reveals that more than eight in ten survey respondents (83 percent) expect their organizations to increase their digital investments in 2019. And more than 40 percent of respondents predict that their organizations will increase their investments by 11 percent or more.
Currently, approximately half of companies surveyed have digitally enabled just three key organizational functions, according to the research. When asked to cite the top barriers to transformation, more than one-third (35 percent) of respondents flagged “cost or lack of funding,” second only to security concerns (40 percent).
However, most companies surveyed (76 percent) expect the cost savings from IT services modernization to help fund their digital strategy. Within the next three years, companies intend to greatly ramp up their efforts, and more than half of respondents (58 percent) expect every business unit to be digitally enabled in the next three years.
“Companies overwhelmingly recognize that digital innovation is now a requirement for them to compete and succeed,” said Dan Hushon , senior vice president and chief technology officer, DXC Technology. “The survey findings point to perhaps the most rapid, dramatic and sophisticated effort at reinvention that major businesses have attempted in many decades, and those surveyed are committed to investing to make digital happen.”
Survey respondents also linked digital transformation to profits. More than two-thirds (68 percent) say the annual profitability of their organizations has increased over the past three years thanks to their organizations’ digital strategy, and 74 percent say they expect it to rise over the next three years.
“We strongly believe that we can make the customer experience easier and simpler while leading to better outcomes through digital technology, and that will continue to drive our market share,” said survey report interviewee Neesha Hathi, executive vice president and chief digital officer at Charles Schwab. “Digital transformation also helps us scale our services while driving down costs for our clients.”
Digital decision drivers
The report reveals what companies aim to achieve by digitally remaking themselves, as well as the challenges they must overcome and the cultural changes they need to make. Other key findings include:
- Digital and business strategy formulation are completely or almost completely aligned at 72 percent of companies.
- Three-fourths (75 percent) of respondents say digital transformation will lead to greater agility, and 76 percent report that modern digital IT infrastructures better position their companies to produce value for their stakeholders.
- Approximately one-third (33 percent) of respondents say the lack of a tech-savvy workforce is a barrier to transformation.
- Nearly three-fourths (72 percent) of companies agree that a change in culture is necessary to digitally transform any organization. That figure is even higher for companies in developing regions and those that have implemented digital strategies only in the past two years.
“Our research indicates that digital strategy will continue to be a major area of investment – amounting to a dramatic effort at corporate reinvention. But getting it right will be a continuing challenge,” said Gilda Stahl, managing editor, thought leadership, at The Economist Intelligence Unit. “Defining your digital strategy clearly, ensuring digital literacy in every relevant role and recruiting digital-savvy employees are all essential to guaranteeing that digital investment yields positive business outcomes.”
Key regional and industry trends
- Companies that are further advanced – for example, those headquartered in North America and Europe and those in the financial services and manufacturing industries – tend to place greater emphasis on cross-functional collaboration, possibly because this helps them to optimize the digital investments they’ve already made.
- Financial services companies are more likely to stress AI/machine learning and blockchain while, for manufacturing companies, cloud computing and IoT are especially important.
- Social media is a somewhat higher priority for retailers than for other industries, given the importance to them of developing digital channels for sales and marketing. These tools play a growing role at marketing and communications firms as well.
Methodology
The Economist Intelligence Unit surveyed 621 senior executives in September and October 2018 to discover where companies are in their digital development and what they want to achieve with digital transformation. Respondents were members of the C-suite or held other senior leadership roles, including executive vice presidents, managing directors, and directors. Companies surveyed ranged in size from US$500 million to US$5 billion or more in annual revenue. Respondents were widely distributed across functions and industries — healthcare, manufacturing, retail and insurance are the biggest sectors represented.
Resources:
- 2019: The Year of Digital Decisions report
- Infographic: “Fostering an enterprise digital culture”
- Blog post: “Survey: Companies poised to go all-in on digital transformation in 2019”
- Follow DXC Technology on Twitter: https://twitter.com/DXCTechnology
- Join the conversation: #DXCDigitalDirections
About DXC Technology
As the world's leading independent, end-to-end IT services company, DXC Technology (NYSE: DXC) leads digital transformations for clients by modernizing and integrating their mainstream IT, and by deploying digital solutions at scale to produce better business outcomes. The company’s technology independence, global talent, and extensive partner network enable 6,000 private and public-sector clients in 70 countries to thrive on change. DXC is a recognized leader in corporate responsibility. For more information, visit dxc.technology and explore THRIVE , DXC’s digital destination for changemakers and innovators.
About The Economist Intelligence Unit
The Economist Intelligence Unit (EIU) is the research and analysis division of The Economist Group, the sister company to The Economist newspaper. Created in 1946, EIU has nearly 70 years’ experience in helping businesses, financial firms and governments to understand how the world is changing and how that creates opportunities to be seized and risks to be managed.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190115005239/en/
Contact:
Allison Wilson, Corporate Media Relations +1.352.502.9539, dwilson215@dxc.com
Donna Jenks, Corporate Media Relations +1.630.306.9989, donna.jenks@dxc.com
Jonathan Ford, Investor Relations +1.703.245.9700, jonathan.ford@dxc.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
